%0
Generic
%T
Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
%A Sweeney, Christopher
%A Chen, Yu-Hui
%A Carducci, Michael Anthony
%A Liu, Glenn
%A Jarrard, David Frasier
%A Eisenberger, Mario A.
%A Wong, Yu-Ning
%A Hahn, Noah M.
%A Kohli, Manish
%A Vogelzang, Nicholas J.
%A Cooney, Matthew M.
%A Dreicer, Robert
%A Picus, Joel
%A Shevrin, Daniel H.
%A Hussain, Maha
%A Garcia, Jorge A.
%A DiPaola, Robert S.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2014
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2